Gene · 2207
Papers2,891
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,891
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The novel mechanism facilitating chronic hepatitis B infection: immunometabolism and epigenetic modification reprogramming. | Front Immunol | 2024 | 38288308 | PubTator, text mining | PubMed |
| Macrophage barrier in the tumor microenvironment and potential clinical applications. | Cell Commun Signal | 2024 | 38279145 | PubTator, text mining | PubMed |
| Identification of shared pathogenetic mechanisms between COVID-19 and IC through bioinformatics and system biology. | Sci Rep | 2024 | 38267482 | PubTator, text mining | PubMed |
| Comprehensive Analysis Reveals Prognostic and Therapeutic Immunity-Related Biomarkers for Pediatric Metastatic Osteosarcoma. | Medicina (Kaunas) | 2024 | 38256356 | PubTator, text mining | PubMed |
| Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis. | Int J Mol Sci | 2024 | 38256115 | PubTator, text mining | PubMed |
| Identification of the Linear Fc-Binding Site on the Bovine IgG1 Fc Receptor (boFcγRIII) Using Synthetic Peptides. | Vet Sci | 2024 | 38250930 | PubTator, text mining | PubMed |
| Multidrug-Resistant Sepsis: A Critical Healthcare Challenge. | Antibiotics (Basel) | 2024 | 38247605 | PubTator, text mining | PubMed |
| Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma. | Nat Commun | 2024 | 38245530 | PubTator, text mining | PubMed |
| Chimeric Antigen Cytotoxic Receptors for In Vivo Engineering of Tumor-Targeting NK Cells. | Immunohorizons | 2024 | 38240638 | PubTator, text mining | PubMed |
Unraveling the underlying pathogenic factors driving nonalcoholic steatohepatitis and hepatocellular carcinoma: an in-depth analysis of prognostically relevant gene signatures in hepatocellular carcinoma. | J Transl Med | 2024 | 38238845 | PubTator, text mining | PubMed |
| Function and mechanism of TREM2 in bacterial infection. | PLoS Pathog | 2024 | 38236825 | PubTator, text mining | PubMed |
| Restraining of glycoprotein VI- and integrin α2β1-dependent thrombus formation by platelet PECAM1. | Cell Mol Life Sci | 2024 | 38236412 | PubTator, text mining | PubMed |
| Endogenous Signaling Molecule Activating (ESMA) CARs: A Novel CAR Design Showing a Favorable Risk to Potency Ratio for the Treatment of Triple Negative Breast Cancer. | Int J Mol Sci | 2024 | 38203786 | PubTator, text mining | PubMed |
| Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma. | J Immunother Cancer | 2024 | 38191242 | PubTator, text mining | PubMed |
| Integration of bioinformatics analysis to identify possible hub genes and important pathways associated with clear cell renal cell carcinoma. | Urologia | 2024 | 38159064 | PubTator, text mining | PubMed |
| Diagnostic biomarker for type 2 diabetic peripheral neuropathy via comprehensive bioinformatics analysis. | J Diabetes | 2024 | 38018513 | PubTator, text mining | PubMed |
| Evidence from Machine Learning, Diagnostic Hub Genes in Sepsis and Diagnostic Models based on Xgboost Models, Novel Molecular Models for the Diagnosis of Sepsis. | Curr Med Chem | 2024 | 37921181 | PubTator, text mining | PubMed |
| Novel biomarkers identified by weighted gene co-expression network analysis for atherosclerosis. | Herz | 2024 | 37721628 | PubTator, text mining | PubMed |
| Transcriptional profiling specifies the pathogen-specific human host response to infectious keratitis. | Front Cell Infect Microbiol | 2023 | 38274739 | PubTator, text mining | PubMed |
| Comparison of Transcriptomic Analysis of the Conjunctiva in Glaucoma-Treated Eyes with Dry Eyes and Healthy Controls. | Biomolecules | 2023 | 38254630 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2207/papers?page=9